Article
High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome
7 Mar 2017
Abstract excerpt
=0.001 and <0.0001, respectively). Taken together, these findings suggest that differentially high expression of miR-196b in diagnostic marrow samples of pediatric AML is associated with unfavorable outcome, and miR-196b potentially can be a novel biomarker for the diagnosis, prognosis and treatment in pediatric AML.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
